SeaCrest Wealth Management’s Organon & Co OGN Stock Holding History

SeaCrest Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,851	Closed	-$162K	–	687
2024 Q4	$162K	Sell	10,851 -5,367	-33%	-$87.5K	0.02%	630
2024 Q3	$310K	Buy	16,218 +3,999	+33%	+$82.9K	0.03%	483
2024 Q2	$253K	Sell	12,219 -20,491	-63%	-$407K	0.03%	513
2024 Q1	$615K	Buy	32,710 +13,706	+72%	+$235K	0.08%	272
2023 Q4	$274K	Buy	+19,004	New	+$259K	0.03%	485
2022 Q3	–	Sell	-3,995	Closed	-$135K	–	1213
2022 Q2	$135K	Buy	+3,995	New	+$140K	0.02%	747
2021 Q4	–	Sell	-11,363	Closed	-$373K	–	724
2021 Q3	$373K	Buy	11,363 +891	+9%	+$28.5K	0.05%	428
2021 Q2	$317K	Buy	+10,472	New	+$345K	0.04%	483

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SeaCrest Wealth Management's OGN Position: Q1 2025 in Review

SeaCrest Wealth Management sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 10,851 shares — an estimated $162K sold.

SeaCrest Wealth Management first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $615K in Q1 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

SeaCrest Wealth Management reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
SeaCrest Wealth Management sold 10,851 Organon & Co shares in Q1 2025, an estimated $162K.
SeaCrest Wealth Management first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
SeaCrest Wealth Management's Organon & Co position peaked at $615K in Q1 2024.
720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on SeaCrest Wealth Management's 13F filing for Q1 2025, filed 11 Apr 2025.